These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 38004561)
1. Nanotechnology-Based Drug Delivery Systems to Control Bacterial-Biofilm-Associated Lung Infections. Guo Y; Mao Z; Ran F; Sun J; Zhang J; Chai G; Wang J Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004561 [TBL] [Abstract][Full Text] [Related]
2. Combination and nanotechnology based pharmaceutical strategies for combating respiratory bacterial biofilm infections. Zhang L; Bera H; Wang H; Wang J; Guo Y; Shi C; Cun D; Moser C; Høiby N; Yang M Int J Pharm; 2022 Mar; 616():121507. PubMed ID: 35085729 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary biofilm-based chronic infections and inhaled treatment strategies. Ding L; Wang J; Cai S; Smyth H; Cui Z Int J Pharm; 2021 Jul; 604():120768. PubMed ID: 34089796 [TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections. Huang Z; Kłodzińska SN; Wan F; Nielsen HM Drug Deliv Transl Res; 2021 Aug; 11(4):1634-1654. PubMed ID: 33694082 [TBL] [Abstract][Full Text] [Related]
6. Micro/nanosystems and biomaterials for controlled delivery of antimicrobial and anti-biofilm agents. Bianchera A; Buttini F; Bettini R Expert Opin Ther Pat; 2020 Dec; 30(12):983-1000. PubMed ID: 33078643 [TBL] [Abstract][Full Text] [Related]
7. The role of bacterial biofilms in chronic infections. Bjarnsholt T APMIS Suppl; 2013 May; (136):1-51. PubMed ID: 23635385 [TBL] [Abstract][Full Text] [Related]
9. Polyester-based particles to overcome the obstacles of mucus and biofilms in the lung for tobramycin application under static and dynamic fluidic conditions. Ernst J; Klinger-Strobel M; Arnold K; Thamm J; Hartung A; Pletz MW; Makarewicz O; Fischer D Eur J Pharm Biopharm; 2018 Oct; 131():120-129. PubMed ID: 30063969 [TBL] [Abstract][Full Text] [Related]
10. Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases? Dua K; Shukla SD; Tekade RK; Hansbro PM Drug Deliv Transl Res; 2017 Feb; 7(1):179-187. PubMed ID: 27924468 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients. Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303 [TBL] [Abstract][Full Text] [Related]
12. The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections. Blasi F; Page C; Rossolini GM; Pallecchi L; Matera MG; Rogliani P; Cazzola M Respir Med; 2016 Aug; 117():190-7. PubMed ID: 27492531 [TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Murray TS; Egan M; Kazmierczak BI Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667 [TBL] [Abstract][Full Text] [Related]